Edition:
United States

Nuformix PLC (NFXN.L)

NFXN.L on London Stock Exchange

2.25GBp
--
Change (% chg)

0.00 (+0.00%)
Prev Close
2.25
Open
2.25
Day's High
--
Day's Low
--
Volume
3,562,875
Avg. Vol
1,252,232
52-wk High
4.70
52-wk Low
1.75

Chart for

About

Nuformix PLC, formerly Levrett PLC, is a United Kingdom-based pharmaceutical development company. The Company uses cocrystal technology to develop drugs with programs in oncology supportive care and fibrosis. It uses cocrystal technology to re-engineer the crystalline form of drugs. Its clinical pipeline includes NXP001 and... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 190.77 15.47
EPS (TTM): -- -- --
ROI: -- -11.61 33.71
ROE: -- -35.87 16.38

Earnings vs. Estimates

No consensus analysis data available.